Cite

HARVARD Citation

    Barisa, M. et al. (2022). Preclinical platforms to study therapeutic efficacy of human γδT‐cells for oncology indications. Clinical and translational discovery. 2 (2), p. n/a. [Online]. 
  
Back to record